Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.85% vs 3.82% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.96% vs 9.06% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 67.27% vs -26.24% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 23.42% vs 5.57% in Mar 2024
Compare Profit and Loss Results of Jenburkt Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
151.00
368.00
-217.00
-58.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
151.00
333.00
-182.00
-54.65%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
4.00
-4.00
-100.00%
Raw Materials Consumed
29.00
164.00
-135.00
-82.32%
Power & Fuel Cost
0.00
27.00
-27.00
-100.00%
Employee Cost
45.00
45.00
0.00
0.00%
Operating Expenses
4.00
28.00
-24.00
-85.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
14.00
4.00
10.00
250.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
111.00
289.00
-178.00
-61.59%
Operating Profit (PBDIT) excl Other Income
40.00
44.00
-4.00
-9.09%
Other Income
6.00
3.00
3.00
100.00%
Operating Profit (PBDIT)
47.00
48.00
-1.00
-2.08%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
46.00
40.00
6.00
15.00%
Depreciation
2.00
10.00
-8.00
-80.00%
Profit Before Taxation & Exceptional Items
43.00
30.00
13.00
43.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
43.00
30.00
13.00
43.33%
Provision for Tax
11.00
8.00
3.00
37.50%
Profit After Tax
32.00
21.00
11.00
52.38%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
134.00
101.00
33.00
32.67%
Profit Available for appropriations
166.00
122.00
44.00
36.07%
Appropriations
166.00
122.00
44.00
36.07%
Equity Dividend (%)
180%
15%
165.00
Earnings Per Share
72.65
70.69
1.96
2.77%
Profit And Loss - Net Sales
Net Sales 151.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.85% vs 3.82% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.96% vs 9.06% in Mar 2024
Profit And Loss - Interest
Interest 0.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 67.27% vs -26.24% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 32.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.42% vs 5.57% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
